AVAI — AVAI BIO, INC.
—
OTC ·
Information Technology ·
IT Services ·
CIK 1740797 ·
Last close
$0.22
Market Cap
$30.25M
52W High
$0.50
52W Low
$0.16
ADV30
174,071
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | — | -553,727 | -553,727 | 172,912 | 50,402 | 2,967,398 |
| Sep 2025 | 0 | — | -453,016 | -453,016 | 231,372 | 91,995 | 2,532,131 |
| Jun 2025 | 0 | — | -487,589 | -487,589 | 145,306 | 10,062 | 2,136,767 |
| Mar 2025 | 0 | — | 464,072 | 464,072 | 224,745 | 81,053 | 1,788,617 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-1,146,517
Investing CF
$0
Financing CF
$1,193,849
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$0.00
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-5,612,842
Inventory
—
Receivables
—
ST Investments
—
EBIT TTM
$-1,030,260
Pretax Income TTM
$-1,030,260
Interest Exp TTM
—
Analysts
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Mar 2025 | 0 | -1,142,115 | -1,142,115 | 224,745 | 1,788,617 | — | -1,160,610 |
| Mar 2024 | 0 | -2,128,475 | -2,128,475 | 322,014 | 1,788,580 | — | -1,322,318 |
| Mar 2023 | 276,324 | -348,933 | -348,933 | 241,460 | 874,719 | — | -54,457 |
| Mar 2022 | 921,306 | -126,521 | -126,521 | 454,664 | 860,225 | — | -535,008 |
TTM Snapshot
Revenues TTM
$1,062,852
NetIncome TTM
$-1,176,177
OpCashFlow TTM
$0
Assets (Latest)
$224,745
Forward EPS
—
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| ILLMF | illumin Holdings Inc. | $30.21M | $0.59 | — |
| JG | Aurora Mobile Ltd | $29.23M | $6.24 | — |
| VEEA | VEEA INC. | $31.40M | $0.62 | — |
| BLIV | BeLive Holdings | $26.62M | $2.45 | — |
| DGNX | Diginex Ltd | $35.79M | $1.23 | — |
News headlines (Yahoo Finance, 1h cache)
Avaí Bio and Austrianova Complete GMP Master Cell Bank, Begin Viral Testing for Cell-Based Klotho Anti-Aging Therapy
2026-05-20 12:45 · Yahoo
Avaí Bio and Austrianova to Present Latest Data on Klotho Anti-Aging Therapy at Annual Klotho Conference
2026-04-07 12:00 · Yahoo
Avaí Bio and Austrianova Begin Production of Master Cell Bank for Klotho Anti-Aging Therapy Under GMP Standards
2026-03-03 13:30 · Yahoo
Avant Technologies Completes Rebranding with Name Change to Avaí Bio and Launch of New Website
2026-02-11 13:43 · Yahoo
Avant Technologies Evaluating Advanced Cells for Diabetes Therapy at 15th Annual EPITA Symposium
2026-01-26 13:30 · Yahoo
Avant Technologies Highlights the Critical Role of Cell Encapsulation Technology in Revolutionizing Diabetes Treatment
2025-12-16 13:15 · Yahoo
Avant Technologies and Austrianova Advancing α-Klotho Cell Therapy as Mayo Clinic Study Links Low α-Klotho Levels to Poor Cardiovascular Survival
2025-12-09 13:30 · Yahoo
Avant Technologies and Austrianova Secure Exclusive License for Klotho Producing Cell Line to Advance Anti-Aging Therapies
2025-11-18 13:00 · Yahoo
Avant Technologies Signs Joint Venture to Advance Cell-Based Diabetes Treatment
2025-11-04 13:00 · Yahoo
Avant Technologies and Austrianova Launch Klothonova, Begin Developing Age Related Cellular Therapies Using 'Longevity Protein' Klotho
2025-10-21 12:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.